ATE509100T1 - Chimäre (doppel-) attrappe - Google Patents
Chimäre (doppel-) attrappeInfo
- Publication number
- ATE509100T1 ATE509100T1 AT05799368T AT05799368T ATE509100T1 AT E509100 T1 ATE509100 T1 AT E509100T1 AT 05799368 T AT05799368 T AT 05799368T AT 05799368 T AT05799368 T AT 05799368T AT E509100 T1 ATE509100 T1 AT E509100T1
- Authority
- AT
- Austria
- Prior art keywords
- transcriptional regulatory
- plural
- chimera
- disease
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3519—Fusion with another nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004308952 | 2004-10-22 | ||
| PCT/JP2005/019742 WO2006043722A1 (ja) | 2004-10-22 | 2005-10-20 | キメラ(ダブル)デコイ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE509100T1 true ATE509100T1 (de) | 2011-05-15 |
Family
ID=36203128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05799368T ATE509100T1 (de) | 2004-10-22 | 2005-10-20 | Chimäre (doppel-) attrappe |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8067384B2 (de) |
| EP (1) | EP1803811B1 (de) |
| JP (1) | JP4921975B2 (de) |
| AT (1) | ATE509100T1 (de) |
| CA (1) | CA2583576A1 (de) |
| WO (1) | WO2006043722A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014201462B2 (en) * | 2007-05-11 | 2016-09-29 | Adynxx, Inc. | Gene expression and pain |
| JP5646320B2 (ja) * | 2007-05-11 | 2014-12-24 | アダイニクス, インコーポレイテッド | 遺伝子発現と疼痛 |
| AU2016266076B2 (en) * | 2007-05-11 | 2018-08-30 | Adynxx, Inc. | Gene expression and pain |
| RU2668136C2 (ru) | 2012-05-10 | 2018-09-26 | Эйдинкс, Инк. | Композиции для доставки активных ингредиентов |
| GB201310853D0 (en) * | 2013-06-18 | 2013-07-31 | Ucb Pharma Sa | Method |
| CN106661578B (zh) | 2014-08-15 | 2020-08-04 | 埃迪恩克斯股份有限公司 | 用于疼痛治疗的寡核苷酸诱饵 |
| EP3348637B1 (de) * | 2015-09-09 | 2022-03-09 | AnGes, Inc. | Chimäres lockmittel |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1350514A3 (de) * | 1993-10-29 | 2004-07-07 | The Brigham And Women's Hospital, Inc. | Therapeutische Verwendung von Cis-Element Ködern in vivo |
| AU3881095A (en) | 1994-11-17 | 1996-06-17 | Taiho Pharmaceutical Co., Ltd. | Double-stranded oligonucleotide and carcinostatic agent containing the same as active ingredient |
| DE69636997T2 (de) * | 1995-05-12 | 2007-07-12 | Anges MG Inc., Ibaraki | HEILUNG UND VORBEUGUNG VON DURCH NF-kappaB VERURSACHTEN ERKRANKUNGEN |
| AU753270B2 (en) | 1998-05-21 | 2002-10-10 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
| JP4346233B2 (ja) | 2000-12-27 | 2009-10-21 | アンジェスMg株式会社 | デコイを含む薬学的組成物およびその使用方法 |
| US7060690B2 (en) | 2001-01-22 | 2006-06-13 | Genta Incorporated | Methods and compositions for treating a cell-proliferative disorder using CRE decoy oligomers, BCL-2 antisense oligomers, and hybrid oligomers thereof |
| JP3778357B2 (ja) * | 2001-02-20 | 2006-05-24 | アンジェスMg株式会社 | デコイを含む薬学的組成物およびその使用方法 |
| US20050175539A1 (en) * | 2001-11-22 | 2005-08-11 | Ryuichi Morishita | Compositions inhibiting rejection in organ transplantation and method of using the same |
| DE60231063D1 (de) * | 2002-02-01 | 2009-03-19 | Anges Mg Inc | N zur behandlung von aneurysmen |
| AU2002241343A1 (en) * | 2002-03-29 | 2003-10-13 | Anges Mg, Inc. | Decoy compositions for treating and preventing brain diseases and disorders |
| KR100874798B1 (ko) * | 2002-04-26 | 2008-12-19 | 이인규 | 전사시 dna 결합부위를 포함하는 원형의 아령형 디코이올리고뉴클레오티드 |
| CN1306964C (zh) * | 2002-05-29 | 2007-03-28 | 安琪士摩奇株式会社 | 治疗和预防炎症性疾病的诱饵组合物 |
| US7482158B2 (en) * | 2004-07-01 | 2009-01-27 | Mathison Brian H | Composite polynucleic acid therapeutics |
-
2005
- 2005-10-20 AT AT05799368T patent/ATE509100T1/de not_active IP Right Cessation
- 2005-10-20 JP JP2006543227A patent/JP4921975B2/ja not_active Expired - Lifetime
- 2005-10-20 EP EP05799368A patent/EP1803811B1/de not_active Expired - Lifetime
- 2005-10-20 US US11/662,777 patent/US8067384B2/en active Active
- 2005-10-20 WO PCT/JP2005/019742 patent/WO2006043722A1/ja not_active Ceased
- 2005-10-20 CA CA002583576A patent/CA2583576A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2583576A1 (en) | 2006-04-27 |
| EP1803811A4 (de) | 2008-09-03 |
| EP1803811A1 (de) | 2007-07-04 |
| WO2006043722A1 (ja) | 2006-04-27 |
| US20070259826A1 (en) | 2007-11-08 |
| JP4921975B2 (ja) | 2012-04-25 |
| JPWO2006043722A1 (ja) | 2008-05-22 |
| US8067384B2 (en) | 2011-11-29 |
| EP1803811B1 (de) | 2011-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004015811D1 (de) | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden | |
| DK1799235T3 (da) | Sammensætninger af fosterhudcelleprotein til behandling af hudtilstande, -lidelser eller -sygdomme og fremgangsmåder til fremstilling og anvendelse deraf | |
| DE602007009095D1 (de) | Tetrahydropyrrolopyrimidindione und ihre verwendung als inhibitoren der humanen neutrophilen elastase | |
| EA200900285A1 (ru) | Гетероарильные соединения, применяемые в качестве ингибиторов e1 активирующих ферментов | |
| EA200800664A1 (ru) | Производные пирролопиримидина в качестве ингибиторов syk | |
| CY1117562T1 (el) | Τριαζολοπυριδινες ως αναστολεις φωσφοδιεστερασης για την θεραπεια δερματικων ασθενειων | |
| DK1836169T3 (da) | Sammensætninger og fremgangsmåder til behandling af celleproliferationslidelser | |
| EA200870292A1 (ru) | Соединения на основе имидазола, композиции, содержащие их, и способы их применения | |
| EA200901486A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR | |
| EA201300583A1 (ru) | Вазопротективное и кардиопротективное противодиабетическое лечение | |
| EA200901646A1 (ru) | Ингибиторы рецепторных тирозинкиназ и их применение | |
| EA201500769A1 (ru) | Ингибиторы е1 активирующих ферментов | |
| DK1853271T3 (da) | Fremgangsmåde og præparat til behandling af perifere vaskulære sygdomme | |
| DK3357911T3 (da) | Prolylhydroxylaseinhibitorer og fremgangsmåder til anvendelse | |
| EA201070611A1 (ru) | Ингибиторы человеческой фосфатидилинозитол-3-киназы дельта | |
| ATE540949T1 (de) | Substituierte pteridine zur behandlung von entzündlichen erkrankungen | |
| EA201170052A1 (ru) | Производные тиофена или тиазола и их применение как ингибиторов pi3k | |
| MY148851A (en) | Dihydropyridine derivatives as useful as protein kinase inhibitors | |
| ATE543907T1 (de) | Stresstolerante baumwollpflanzen | |
| ATE522536T1 (de) | Pyrrolopyrazin-kinasehemmer | |
| NO20061194L (no) | Mitotiske kinesininbibitorer | |
| EA200801362A1 (ru) | Пиримидинил бензотиофеновые соединения | |
| EP1803811A4 (de) | Chimäre (doppel-) atrappe | |
| DE112021006630A5 (de) | Stent, insbesondere zur Behandlung von Erkrankungen der Halsschlagader | |
| WO2007136910A3 (en) | Eimmunotherapy for immune suppressed patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |